Pulmozyme 1 MG/ML ampul 2.5ML
Ended Awarded
- Contract number
- SPE2DR26FZ4JU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,032
Award facts
- Contract value 100% obligated
- $9,032.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Pulmozyme 1 mg/ml ampul 2.5ml with a ceiling value of $9,032.30. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of November 13, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems worldwide.
Pulmozyme is a prescription medication used to treat cystic fibrosis by helping to thin mucus in the lungs, making it easier for patients to breathe. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen regularly fulfills delivery orders for specialty medications and medical supplies across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The competitively awarded nature of this transaction and the company's substantial IDC with DLA underscore AmerisourceBergen's capability to meet federal procurement requirements for specialized pharmaceutical products and its role in supporting military medical supply chains globally.
Quick answers
Who was awarded contract SPE2DR26FZ4JU?
SPE2DR26FZ4JU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 12, 2025.
How much is contract SPE2DR26FZ4JU worth?
The government has obligated $9,032 on SPE2DR26FZ4JU.
Is contract SPE2DR26FZ4JU an order under another contract?
Yes. SPE2DR26FZ4JU is a delivery order under SPE2DR25D1050, an indefinite delivery contract.
Was contract SPE2DR26FZ4JU competed?
The extent of competition for SPE2DR26FZ4JU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award